An Open-Label, Single-Centre, Parallel Group, Phase I Study To Compare the Pharmacokinetics of AZD5672 Single Dose in Patients With Renal Impairment and Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 01 May 2009
At a glance
- Drugs AZD 5672 (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 01 May 2009 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
- 01 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Aug 2008 New trial record.